A theoretical quantitative model for evolution of cancer chemotherapy resistance

Por Gatenby Robert A, Silva Ariosto S
Publicado em 2010-04-01

A theoretical quantitative model for evolution of cancer chemotherapy resistance

Por Silva, Ariosto S, Gatenby, Robert A
Publicado em 2010

Adaptation to Survival in Germinal Center is the Initial Step in Onset of Indolent Stage of Multiple Myeloma

Por Silva, Ariosto S., Gatenby, Robert A.
Publicado em 2011

A multiscale model of the bone marrow and hematopoiesis

Por Silva, Ariosto S, Anderson, Alexander R.A., Gatenby, Robert A
Publicado em 2011

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Por Silva, Ariosto, Jacobson, Timothy, Meads, Mark, Distler, Allison, Shain, Kenneth
Publicado no J Vis Exp (2015)

The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion

Por Silva, Ariosto S., Yunes, Jose A., Gillies, Robert J., Gatenby, Robert A.
Publicado em 2009

Adaptive Therapy

Por Gatenby, Robert A., Silva, Ariosto S., Gillies, Robert J., Frieden, B. Roy
Publicado em 2009

Evolutionary approaches to prolong progression-free survival in breast cancer

Por Silva, Ariosto S., Kam, Yoonseok, Khin, Zayar P., Minton, Susan E., Gillies, Robert J., Gatenby, Robert A.
Publicado em 2012

Evolution of Tumor Invasiveness: The Adaptive Tumor Microenvironment Landscape Model

Por Lee, Hyung-Ok, Silva, Ariosto S., Concilio, Susanna, Li, Yue-Sheng, Slifker, Michael, Gatenby, Robert A., Cheng, Jonathan D.
Publicado em 2011

A preclinical assay for chemosensitivity in multiple myeloma

Por Khin, Zayar P., Ribeiro, Maria L. C., Jacobson, Timothy, Hazlehurst, Lori, Perez, Lia, Baz, Rachid, Shain, Kenneth, Silva, Ariosto S.
Publicado em 2013

Buffer Therapy for Cancer

Por Ribeiro, Maria de Lourdes C, Silva, Ariosto S., Bailey, Kate M., Kumar, Nagi B., Sellers, Thomas A., Gatenby, Robert A., Ibrahim-Hashim, Arig, Gillies, Robert J.
Publicado em 2012

Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer

Por Enriquez-Navas, Pedro M., Kam, Yoonseok, Das, Tuhin, Hassan, Sabrina, Silva, Ariosto, Foroutan, Parastou, Ruiz, Epifanio, Martinez, Gary, Minton, Susan, Gillies, Robert J., Gatenby, Robert A.
Publicado no Sci Transl Med (2016)

In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma

Por Tafreshi, Narges K, Silva, Ariosto, Estrella, Veronica C, McCardle, Timothy W, Chen, Tingan, Jeune-Smith, Yolaine, Lloyd, Mark C, Enkemann, Steven A, Smalley, Keiran SM, Sondak, Vernon K, Vagner, Josef, Morse, David L
Publicado em 2013

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

Por Zhao, Xiaohong, Lwin, Tint, Silva, Ariosto, Shah, Bijal, Tao, Jiangchuan, Fang, Bin, Zhang, Liang, Fu, Kai, Bi, Chengfeng, Li, Jiannong, Jiang, Huijuan, Meads, Mark B., Jacobson, Timothy, Silva, Maria, Distler, Allison, Darville, Lancia, Zhang, Ling, Han, Ying, Rebatchouk, Dmitri, Di Liberto, Maurizio, Moscinski, Lynn C., Koomen, John M., Dalton, William S., Shain, Kenneth H., Wang, Michael, Sotomayor, Eduardo, Tao, Jianguo
Publicado no Nat Commun (2017)